Vyant Bio Announces 77,522 Votes Needed to Approve Sale of :

CHERRY HILL, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT), today announced that its special meeting of...

Related Keywords

Andrew Lafrence , Vyant Bio , Group Inc , Vyant Bio Inc , Vyant Bio Or Company , Stemonix Inc , Alliance Advisors , Exchange Commission , Exchange Commission On , Special Meeting , Asset Purchase Agreement , Proxy Statement , Proxy Card , Looking Statements , Private Securities Litigation Reform Act , Pink Open Market , Chief Executive Officer , Chief Financial , Other Otc Vynt , Nc , Iology And Data Science , Mprove Drug Discovery , Omplex Neurodevelopmental , Neurodegenerative , Disorders , Ynt ,